No summary available
No summary available
No summary available
No summary available
Someone you love may face both a mental condition and a substance use challenge. They deserve steady support, starting with you. When more is needed, help is available 24/7. Call or text 988 anywhere in the U.S. Learn more: 988lifeline.org #MHAM2026 #SeeThePerson
Respectful communication about mental health is especially important during times of transition, including housing instability or reentry into the community. Compassionate words signal safety when people need it most. #MHAM2026 #MentalHealthAwarenessMonth
Parents and caregivers are often the first to notice when something feels different. Changes in mood, sleep, appetite or behavior may signal a young person needs support. #MentalHealthAwarenessMonth #SeeThePerson
Sometime in your career, you'll have to say no. Read more from Dr. Andrea Beall about how to professionally say "no" while leaving opportunities open for the future.
No summary available
This blog series by the Resident and New Practitioner Committee is targeted to psychiatric pharmacists seeking their first or a new position. Throughout the spring of 2026, this series will feature interviews with hiring managers in various types of settings.
This blog series by the Resident and New Practitioner Committee is targeted to psychiatric pharmacists seeking their first or a new position. Throughout the spring of 2026, this series will feature interviews with hiring managers in various types of settings.
No summary available
Avoiding difficult conversations can lead to stress, reduced engagement, and low morale. Dr. Maria Blaze shares important tips to help you navigate.
No summary available
No summary available
No summary available
Learn all about Antipsychotic Long-Acting Injectable Pharmacology and Dosing in this module! This is one of six modules in our complimentary Psychotropic LAI Training Program. Register today and get access to the full program and LAI resources.
Curious about LAIs? Need more training? Register for our free Psychotropic LAI Training Program! All registrants get access to 6 recorded webinars with ACPE credit, the LAI pocket guide, LAI administration videos, and an LAI administrative toolkit. Register today and get immediate access.
Pharmacists can play an instrumental role in the administration of psychotropic long-acting injectable (LAI) medications (antipsychotics, naltrexone, buprenorphine). We designed this program to train pharmacists, nurses, and other health care professional interested in administering and/or learning more about LAIs with the goal of reducing barriers and increasing patient access to these important medications.
Alleviate confusion about the use of buprenorphine and methadone in acute care settings through AAPP’s toolkit.
Authored by AAPP members Zoe Karavolis, Emily Leppien and Annette Percy, AAPP has released an FAQ to help clinicians address frequently asked questions regarding the use of buprenorphine and methadone in acute care settings.
AAPP's Psychotropic LAI Training Program is back and full of updates! This grant-funded educational activity is offered complimentary and includes access to 6 webinars and LAI resources like a pocket-guide, administration videos, and more. Register today and help us share this program with others that would find it valuable.
This publication highlights best practices for managing OUD during and after pregnancy and summarizes current evidence on treating perinatal substance use disorder.
Nearly 1 in 5 adolescents and young adults are turning to AI chatbots for advice when they’re sad, angry, nervous or stressed, according to a new study. The findings, from the research institute RAND, represent an increase from early 2025, when the nonprofit conducted a similar survey. At the time, around 13% of respondents said they used chatbots for such advice, but the share rose to 19% in the group’s latest survey in November.
This report used literature review and data analysis to gain insight into existing research and the real-world impact by examining Medicare fee-for-service and Part D data from 2021 to 2023.
No summary available